On August 17, Sunrun rose 8.93% in pre-market trading, trading at approximately $11.09/share, with turnover of $276,600. The rebound comes as multiple institutions reiterated bullish ratings on the stock, reinforcing upside expectations following a sharp post-earnings pullback.

UBS recently adjusted its price target on Sunrun to $19 from $20 while maintaining a Buy rating. RBC Capital Markets also cut its target to $14 from $18 but kept its Outperform rating, citing near-term ramping challenges that are delaying but not derailing growth and margin expansion. The consensus analyst target currently stands at $16.36, implying approximately 47% upside from recent levels.

The stock had sold off sharply after its Q2 report on August 5, despite earnings of $0.42 per share significantly beating the $0.24 consensus estimate and revenue of $870 million surpassing expectations. The decline was driven by a reduction in full-year cash generation guidance to $200 million-$375 million from a prior range of $250 million-$450 million, attributed to lower order volumes and higher capital costs. The current pre-market move suggests investors are reconsidering the valuation gap between consensus targets and the depressed share price.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)